Resource Use, Costs, and Utility Estimates for Patients with Cystic Fibrosis with Mild Impairment in Lung Function: Analysis of Data Collected Alongside a 48-Week Multicenter Clinical Trial
Authors:
- Chelsea A. GrussemeyerCGChelsea A. Grussemeyer
- Joëlle Y. FriedmanJFJoëlle Y. Friedman
- Michaela A. DinanMDMichaela A. Dinan
- Li LinLLLi Lin
- Kevin A. SchulmanKSKevin A. Schulman
- Shelby D. ReedSRShelby D. Reed
- 1 March 2012
- journal article
- research article
- Published by Elsevier in Value in Health
- Vol. 15 (2) , 277-283
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Denufosol Tetrasodium in Patients with Cystic Fibrosis and Normal to Mildly Impaired Lung FunctionAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Cystic fibrosis lung disease starts in the small airways: Can we treat it more effectively?Pediatric Pulmonology, 2010
- Design and Analysis Issues for Economic Analysis Alongside Clinical TrialsMedical Care, 2009
- Cystic Fibrosis Pulmonary GuidelinesAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Risk Factors For Rate of Decline in Forced Expiratory Volume in One Second in Children and Adolescents with Cystic FibrosisThe Journal of Pediatrics, 2007
- Health values of adolescents with cystic fibrosisThe Journal of Pediatrics, 2003
- Factors Influencing Outcomes in Cystic FibrosisChest, 2003
- The Health Utilities Index (HUI®) system for assessing health-related quality of life in clinical studiesAnnals of Medicine, 2001
- Patterns of medical practice in cystic fibrosis: Part I. Evaluation and monitoring of health status of patientsPediatric Pulmonology, 1999
- Patterns of medical practice in cystic fibrosis: Part II. Use of therapiesPediatric Pulmonology, 1999